Navigation Links
From microscope to stethoscope: The MUHC's public lecture series begins its 2nd season tomorrow
Date:10/2/2007

Montreal, October 2nd, 2007 - From Microscope to Stethoscope, the distinguished public lecture series organized by the Research Institute of the McGill University Health Centre (MUHC), is embarking on its second season tomorrow.

For this opening conference, Dr. Vassilios Papadopoulos, Director of the Research Institute of the MUHC, will be sharing the hope that his current research may bring to patients suffering from Alzheimers disease. Alzheimers disease is one of the most devastating neurodegenerative pathologies, for both patients and families; unfortunately its origins are still a mystery, explains Dr Papadopoulos. His latest laboratory findings could lead to remarkable therapeutic advances and relieve the difficulties doctors currently have in terms of diagnosis and treatment.

The second lecture will be given on Monday, November 7, 2007, by Dr. Lawrence Rosenberg, a world expert in diabetes, and the third one will be by Dr. Ronald Olivenstein, MUHC Asthma Clinic Director, on Wednesday, December 3, 2007.

"Again this year, three of our most brilliant researchers invite you on a journey into a possible future, when current research has already turned into innovative treatments for patients, declared Dr. Arthur T. Porter, Director General of the MUHC. These lectures will give you a direct look at the intellectual vitality that fills our research laboratories and the enormous impact of this work on our daily lives.

The lectures will take place at the Montreal General Hospital in Livingston Hall (Rom L6-500) starting at 7:30 p.m. Admission is free and anyone interested is welcome.

The speakers will take questions from audience members during a discussion period following each lecture.


'/>"/>

Contact: Isabelle Kling
isabelle.kling@muhc.mcgill.ca
514-934-1934
McGill University Health Centre
Source:Eurekalert

Page: 1

Related medicine news :

1. Controversial deal on public access of the human genome map
2. Defibrillators In Public Places Will Help Cardiac Patients
3. WHO To Support Public Health Threats
4. Public Defibrillators Found To Improve Survival Rate
5. FDA Issues Public Health Advisory on Tysabri, a New Drug for MS
6. WHO Steps Up To Create A Public Awareness About The Consequences Of Exposure To Radon
7. Disaster Planning Guide From Harvard Health Publications
8. India to maintain Public domain Registry database of clinical trials conducted in India.
9. Smoking Ban Believed To Enjoy Widespread Public Acceptance In Scotland
10. Evidences that Better Health Care Facility is Offered By Public Hospitals.
11. UK public misled over downgrading cannabis: Govt
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... RIDGE, N.J. (PRWEB) , ... October 13, 2017 , ... ... annual Holly Day Market. Featuring a collection of specialty vendors and unique items from ... of personalized and quality-focused health and wellness services offered by the VNA. The ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Agile Software Development, has been awarded a contract by the Center for Medicare ... (BPA) aims to accelerate the enterprise use of Agile methodologies in a consistent ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest and fastest ... to open a flagship location in Covington, LA at 401 N. U.S. Highway 190, ... next to Office Depot in the Holiday Square shopping center. Its location allows it ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: , ... to enable prevention of a major side effect of chemotherapy in children. Cisplatin ... patients. For cisplatin, hearing loss is FDA listed on-label as a dose limiting ...
(Date:10/12/2017)... Mich. (PRWEB) , ... October 12, 2017 , ... ... has been named one of Michigan’s 2017 Best and Brightest in Wellness® by ... Brightest in Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. to ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... SAN DIEGO , Oct. 12, 2017 ... has recognized the company with their  2017 New Product Innovation ... is based on extensive primary and secondary medical device market ... AVACEN Medical, through its first-to-market OTC, drug-free pain relief product, ... a unique approach to treating fibromyalgia widespread pain. ...
(Date:10/11/2017)... 11, 2017  True Health, a leader in ... effort during National Breast Cancer Awareness month to ... Research recently ... that more than 10 million American women are ... BRCA1 or BRCA2 and have not had testing. These ...
(Date:10/5/2017)... Ill. , Oct. 5, 2017  In ... Association of Oral and Maxillofacial Surgeons (AAOMS) released ... opioids – to be used as a first-line ... pain. Recognizing ... the AAOMS White Paper "Opioid Prescribing: Acute and ...
Breaking Medicine Technology: